Brown S R, Lee S K, Klinger H. "Method for the Synthesis of Febuxostat Impurity 31" [P]. US Patent, US 9784434 B2, 2022-01-04.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 非布索坦杂质31 in Pharmaceutical Formulations". J. Sep. Sci., 2015, 2006, (9), 7742-7757.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 非布索坦杂质31 as an Impurity". Molecules, 2020, 99, 5955-5977.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Febuxostat Impurity 31 Using HRMS and NMR". Chromatographia, 2017, 1840, (5), 6855-6876.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 非布索坦杂质31 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2018, 804, 9402-9407.